Breaking News Instant updates and real-time market news.

MU

Micron

$28.59

0.67 (2.40%)

, QCOM

Qualcomm

$52.70

0.08 (0.15%)

07:35
08/08/17
08/08
07:35
08/08/17
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Monday in Micron (MU), Qualcomm (QCOM), Delta Air Lines (DAL), Procter & Gamble (PG), Johnson Controls (JCI), Amicus (FOLD), Avon Products (AVP), LendingClub (LC), Norwegian Cruise Line (NCLH), and Bunge (BG).

MU

Micron

$28.59

0.67 (2.40%)

QCOM

Qualcomm

$52.70

0.08 (0.15%)

DAL

Delta Air Lines

$50.75

0.14 (0.28%)

PG

Procter & Gamble

$91.44

0.77 (0.85%)

JCI

Johnson Controls

$39.78

0.61 (1.56%)

FOLD

Amicus

$13.90

0.67 (5.06%)

AVP

Avon Products

$2.96

0.09 (3.14%)

LC

LendingClub

$5.46

0.25 (4.80%)

NCLH

Norwegian Cruise Line

$56.65

-0.25 (-0.44%)

BG

Bunge

$77.26

0.92 (1.21%)

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 10

    Aug

  • 14

    Aug

  • 29

    Aug

  • 06

    Sep

MU Micron
$28.59

0.67 (2.40%)

07/31/17
WELS
07/31/17
NO CHANGE
WELS
Wells Fargo downgrades Semiconductor sector to Market Weight
Wells Fargo analyst David Wong downgraded the Semiconductor sector to Market Weight from Overweight. Recent earnings reports from chip companies suggest that year-over-year growth will likely plateau or perhaps even decelerate over the next few months, Wong tells investors in a research note. He believes many chip stocks now have "elevated multiples" off calendar 2018 earnings estimates. Wong still sees good investment opportunities in some specific stocks, however, and reiterates Outperform ratings on Intel (INTC), Qualcomm (QCOM), Micron (MU), AMD (AMD), Skyworks (SWKS) and Microsemi (MSCC).
07/27/17
STFL
07/27/17
NO CHANGE
STFL
Micron has positive read through from Samsung comments, says Stifel
Stifel analyst Kevin E. Cassidy reports that Samsung indicated that conditions for memory suppliers would be favorable at least through the end of the year. Additionally, Cassidy thinks that the company's comments indicate that it is looking to maintain a supply/demand balance. He views Samsung's comments as positive for Micron and says they should alleviate the fears of the latter company's investors. The analyst keeps a Buy rating on Micron.
07/26/17
SBSH
07/26/17
NO CHANGE
Target $45
SBSH
Buy
Micron selloff yesterday a buying opportunity, says Citi
Citi analyst Christopher Danely recommends using the selloff yesterday in shares of Micron Technology as a buying opportunity. Fears of weaker DRAM pricing moved the stock lower after Hynix announced it will increase DRAM capital expenditures and expects supply tightness in DRAM to ease in the second half of 2017, Danely tells investors in a research note. The analyst does not believe this level of capacity increase is enough to materially weaken the DRAM market. He keeps a Buy rating on Micron shares with a $45 price target.
08/01/17
SBSH
08/01/17
NO CHANGE
Target $45
SBSH
Buy
Micron recent pullback a buying opportunity, says Citi
Citi analyst Christopher Danely attributes the 12% pullback in shares of Micron over the past week to fears of memory overcapacity. Micron has traded down because of fears of a DRAM downturn driven by an increase in DRAM capital expenditures, Danely tells investors in a research note. DRAM capex in 2017 has increased from $8.9B to $9.9B year-over-year, but it is still not enough to cause a downturn, the analyst contends. He reiterates a Buy rating on Micron with a $45 price target.
QCOM Qualcomm
$52.70

0.08 (0.15%)

08/07/17
MSCO
08/07/17
NO CHANGE
Target $117.5
MSCO
Equal Weight
NXP Semiconductors target raised above deal price to $117 at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach believes NXP Semiconductors (NXPI) shareholders "have the upper hand" in seeking to push for a higher takeout price from Qualcomm (QCOM), while also thinking a higher bid would be "inconsequential" to Qualcomm's balance sheet and deal accretion. The analyst, who sees momentum building for a higher deal price and a "hard time believing" Qualcomm would walk away rather than raise the price and get a deal done, raised his price target on NXP to $117.50 from $110. He keeps an Equal Weight rating on NXP shares.
07/20/17
COWN
07/20/17
NO CHANGE
Target $70
COWN
Qualcomm customers unlikely to take business to Intel, says Cowen
Cowen analyst Timothy Arcuri said the June quarter for Qualcomm (QCOM) was okay while the September quarter outlook was bad because Samsung (SSNLF) now is withholding full royalties on top of Apple (AAPL). The analyst said there aren't many more levers these customers can pull short of taking their business to Intel (INTC), but he believes that is unlikely given the performance gap. Arcuri believes the risk/reward is still favorable and maintained his Outperform rating and $70 price target on Qualcomm shares.
07/20/17
SBSH
07/20/17
NO CHANGE
Target $55
SBSH
Neutral
Qualcomm royalty rates will continue to decline, says Citi
Citi analyst Christopher Danely views Qualcomm's (QCOM) Q3 results as mixed and notes earnings guidance was reduced due to lower royalties and higher expenses. Qualcomm's royalty rates will continue to decline and the NXP Semiconductors (NXPI) deal "may be fraught with problems," Danely tells investors in a research note. He keeps a Neutral rating on the shares with a $55 price target.
DAL Delta Air Lines
$50.75

0.14 (0.28%)

07/14/17
BERN
07/14/17
NO CHANGE
BERN
Delta Air Lines guidance positive, valuation attractive, says Bernstein
Bernstein analyst David Vernon says that Delta reported in-line Q2 results and provided "positive" guidance. Calling the stock's valuation "attractive," the analyst raised his price target on the shares to $65 from $60 and keeps an Outperform rating on the stock.
07/27/17
RAJA
07/27/17
NO CHANGE
RAJA
Strong Buy
Spirit Airlines selloff overdone on fare weakness comments, says Raymond James
Raymond James analyst Savanthi Syth attributes the selloff in Spirit Airlines (SAVE) shares, and those of other U.S. airline peers, to the company's commentary about fare weakness spreading to a larger number of markets in the last few weeks and signals that the pressure is due to United (UAL) being aggressive with pricing. However, he believes the pullback is overdone, stating that he doesn't believe this is sustainable given United's stated goal to close its margin gap with Delta (DAL). He has a Strong Buy rating on Spirit Airlines shares, which are down nearly 20% in afternoon trading.
07/10/17
OPCO
07/10/17
NO CHANGE
OPCO
Oppenheimer recommends buying American Airlines, United Continental
Oppenheimer analyst Ari Wald continues to make the case that interest rates are bottoming, reflationary sectors are positioned for a stronger second half, and market internals should strengthen as well. The analyst sees additional upside for both Banks and Transports, and within the last, its high-conviction idea is to keep buying airlines, such as Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), and United Continental (UAL). Elsewhere in Transports, Wald is bullish on the breakout in shares of FedEx (FDX) and Old Dominion (ODFL), and views Norfolk Southern (NSC) and Landstar System (LSTR) as attractive pre-breakout candidates.
06/29/17
BOFA
06/29/17
NO CHANGE
BOFA
BofA/Merrill raises Airline estimates, Delta and Southwest best positioned
BofA/Merrill analyst Andrew Didora raised Airline estimates and price target to reflect lower fuel pricing and remains positive on the industry said to remain selective into second-half 2017. The analyst believes Buy rated Delta Air Lines (DAL) and Southwest (LUV) are best positioned for sequential unit revenue improvement in the second half due to decelerating and easing comps and raised their price targets to $71 and $75 from $64 and $62, respectively. The analyst expects capacity to increase modestly in 2018 to +3.4% from +2.8% in 2017 and expects Delta to accelerate capacity growth to +1.9% and Southwest to +5%. As part of the sector note, Didora raised Buy rated United Continental's (UAL) price target to $105 from $85, Alaska Air's (ALK) to $120 from $115, Spirit Airlines' (SAVE) down to $68 from $75, and raised Underperform rated American Airlines' (AAL) to $42 from $40 and lowered Hawaiian Holdings' (AAL) to $43 from $47.
PG Procter & Gamble
$91.44

0.77 (0.85%)

07/17/17
DBAB
07/17/17
NO CHANGE
Target $90
DBAB
Hold
Procter & Gamble unlikely to miss near-term expectations, says Deutsche Bank
Deutsche Bank analyst Faiza Alwy believes Procter & Gamble's decision to not give Trian's Nelson Peltz a board seat as a sign that management is confident in its strategy and is unlikely to miss expectations over at least the next few months. The analyst notes the Wall Street Journal's reporting indicates that contrary to speculation from analysts, Trian is not seeking a breakup of the company. This idea was a non-starter given substantial dis-synergies and tax leakage, Alwy tells investors in a research note. The analyst keeps a Hold rating on the shares with a $90 price target.
05/04/17
SUSQ
05/04/17
NO CHANGE
Target $41
SUSQ
Positive
Trade Desk wins Procter & Gamble as a customer, says Susquehanna
As reported by AdvertisingAge today, Procter & Gamble (PG) is moving its DSP business to Trade Desk's (TTD) platform in North America, as well as other geographies. Susquehanna analyst Shyam Patil said the win broadens Trade Desk's base of Tier 1 advertising partners and validates the company's market leadership and its ability to rapidly gain programmatic share. The analyst rates Trade Desk a Positive with a $41 price target.
03/21/17
JPMS
03/21/17
INITIATION
Target $98
JPMS
Neutral
Procter & Gamble initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Procter & Gamble with a Neutral rating and $98 price target.
03/06/17
03/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MetLife (MET) downgraded to Neutral from Buy at BofA/Merrill with analyst Seth Weiss saying shares are now trading above the level of the disappointing fourth quarter earnings report and prefers Prudential (PRU) given it benefits more from improving interest rates and easing regulations. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at B. Riley with analyst Linda Bolton Weiser saying that while the stock is up 11% from the December low, the company's fundamentals have weakened. The analyst cut her price target for the shares to $91 from $106. 3. GoPro (GPRO) downgraded to Sell from Neutral at Goldman with analyst Simona Jankowski saying the company faces "significant challenges" amid camera market saturation, product rollout issues in the holiday season, and a disappointing entry into the drone market. The analyst sees risk to consensus estimates and views the stock as overvalued. 4. Hawaiian Electric (HE) downgraded to Underperform from In Line at Evercore ISI with analyst Greg Gordon saying he believes the risk/return for shares is skewed to the downside and estimates a "significantly lower total return" compared to other utilities he covers. He maintains a $31 price target on Hawaiian Electric shares. 5. Akorn (AKRX) downgraded to Hold from Buy at Deutsche Bank with analyst Gregg Gilbert saying the risk/reward is more balanced following the recent rally in the shares. Upside from current levels will have more to do with the "hard-to-call dynamics of new product approvals vs. base business erosion," Gilbert tells investors in a research note. He cut his price target for the shares to $24 from $28. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JCI Johnson Controls
$39.78

0.61 (1.56%)

07/28/17
ATLE
07/28/17
DOWNGRADE
ATLE
Neutral
Johnson Controls downgraded to Neutral from Overweight at Atlantic Equities
07/28/17
07/28/17
UPGRADE

Buy
Follow-up: Johnson Controls upgraded to Buy following pullback at Gabelli
As previously reported, Gabelli upgraded Johnson Controls to Buy from Hold. Analyst Brian Sponheimer said Johnson's Q3 report was disappointing but but said shares are trading at a discount and the Power Solutions business is underappreciated and is set up for an easy comp in FY18.
08/07/17
MSCO
08/07/17
NO CHANGE
Target $46
MSCO
Overweight
Johnson Controls underperformance is unsustainable, says Morgan Stanley
Morgan Stanley analyst Nigel Coe said Johnson Controls' current underperformance is unsustainable and sees several catalysts over the next year to drive shares higher including a CEO change, Power divestiture, and free cash flow generation. Coe said shares are cheap and discount many issues, and sees so much value that can be unlocked. The analyst rates Johnson Controls an Overweight and lowered his price target to $46 from $51 to reflect a discounted valuation for Power Solutions.
07/28/17
GABE
07/28/17
UPGRADE
GABE
Buy
Johnson Controls upgraded to Buy from Hold at Gabelli
FOLD Amicus
$13.90

0.67 (5.06%)

01/24/17
01/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tableau (DATA) upgraded to Buy from Neutral at Citi with analyst Walter Pritchard saying consensus estimates for fiscal 2017 look low. Revenue transition impacted numbers more than the Street realized in 2016, Pritchard tells investors in a research note. The analyst raised his price target for the shares to $64 from $50. 2. Agrium (AGU) upgraded to Outperform from Market Perform at Cowen, while CF Industries (CF), Mosaic (MOS), and Potash (POT) were upgraded to Market Perform from Underperform. 3. Calithera Biosciences (CALA) upgraded to Neutral from Sell at Citi with analyst Robyn Karnauskas citing her conversation with management. Management now appears more open to partnering, Karnauskas tells investors in a research note. 4. Home Bancshares (HOMB) upgraded to Buy from Hold at Sandler O'Neill. 5. Amicus (FOLD) upgraded to Outperform from Neutral at Baird with analyst Michael Ulz saying the company removed two overhangs by providing regulatory clarity for Galafold in the U.S. as well as a strengthening its balance sheet. Ulz raised his price target to $10 from $7 on Amicus shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
JPMS
07/11/17
NO CHANGE
JPMS
Overweight
Amicus could be up 15%-20% on today's news, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Amicus Therapeutics could be up 15%-20% today on news of the FDA confirming that the regulatory filing for migalastat for the treatment of Fabry can now be submitted. The stock in premarket trading is up 31% to $13.45. The analyst estimates that a U.S. launch of migalastat is now moved up by two years. Rama has an Overweight rating on Amicus.
06/05/17
JPMS
06/05/17
NO CHANGE
Target $13
JPMS
Overweight
Amicus shares can double on positive zorblisa data, says JPMorgan
JPMorgan analyst Anupam Rama believes investor sentiment remains very low on Amicus Therapeutics' Phase 3 readout of zorblisa. The Phase 3 Essence data for the treatment of epidermolysis bullosa are expected in Q3. The trial is "high-risk/high-reward," Rama tells investors in a research note. The analyst says he's taking a "very conservative" approach for zorblisa with $300M in peak sales and a 40% probability of success. Rama believes the stock at current levels reflects no value for zorblisa. On positive data, Amicus shares have the potential to double, Rama writes. On negative data, he sees only "sentiment based" downside of 5%-15%. The analyst keeps an Overweight rating on Amicus with a $13 price target.
07/11/17
COWN
07/11/17
NO CHANGE
Target $16
COWN
Outperform
Amicus price target raised to $16 from $10 at Cowen
AVP Avon Products
$2.96

0.09 (3.14%)

07/06/17
DADA
07/06/17
INITIATION
Target $4.25
DADA
Neutral
Avon Products initiated with a Neutral at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Avon Products with a Neutral and a $4.25 price target saying she does not see a change in the "status quo" to drive valuation higher near-term.
08/04/17
DBAB
08/04/17
DOWNGRADE
Target $3
DBAB
Hold
Avon Products downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Faiza Alwy downgraded Avon Products to Hold saying the CEO change suggests that a business recovery, should there be one, is more than 12 months away. To reflect lowered estimates following"another weak quarter" from Avon, the analyst cut her price target for the shares to $3 from $5. The stock closed yesterday down 11% to $3.00.
08/04/17
08/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) was downgraded to Hold from Buy at Deutsche Bank and to Neutral from Buy at DA Davidson. 2. Teva (TEVA) was downgraded to Market Perform from Outperform at Cowen, to Neutral from Outperform at Credit Suisse, and to Underperform from Outperform at RBC Capital. 3. Ford (F) downgraded to Neutral from Buy at Nomura Instinet with analyst Anindya Das citing uncertainties surrounding North America and European growth. 4. Avon Products (AVP) downgraded to Hold from Buy at Deutsche Bank with analyst Faiza Alwy saying the Chief Executive Officer change suggests that a business recovery, should there be one, is more than 12 months away. 5. CommScope (COMM) was downgraded to Hold from Buy at Cross Research, to Neutral from Buy at Longbow, and to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/16
SBSH
10/21/16
NO CHANGE
Target $8
SBSH
Buy
Avon Products price target raised to $8 from $6 at Citi
Citi analyst Wendy Nicholson raised her price target for Avon Products to $8 saying the shares are now more "investable." Debt refinancing has allayed bankruptcy concerns while an investment by Cerberus has boosted confidence in management, Nicholson tells investors in a research note. The analyst keeps a Buy rating on the shares.
LC LendingClub
$5.46

0.25 (4.80%)

08/03/17
OPCO
08/03/17
UPGRADE
OPCO
Outperform
LendingClub upgraded to Outperform from Perform at Oppenheimer
08/03/17
08/03/17
UPGRADE
Target $7

Outperform
LendingClub upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Jed Kelly upgraded LendingClub to Outperform from Perform, with a $7 price target, as he believes it is creating a sticker investor base through a higher Bank/Retail mix, while utilizing its strong balance sheet to develop a potentially large securitization channel.
05/01/17
05/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Capital One (COF) upgraded to Buy from Hold at Deutsche Bank with analyst David Ho saying loss curves for the bulk of the company's recent card vintage growth should continue to improve. The analyst keeps a $98 price target for the shares. 2. First Solar (FSLR) upgraded to Neutral from Underperform at Credit Suisse with analyst Andrew Hughes citing the potential that Suniva's Section 201 trade complaint succeeds combined with a 23% short interest in the name. 3. Dunkin' Brands (DNKN) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer saying he thinks that initiatives being taken by the company, including "renewed focus on coffee and profitability," will "improve franchisee profitability, core customer satisfaction," and revenue growth. 4. Waters (WAT) upgraded to Buy from Neutral at Janney Capital with analyst Paul Knight saying he expects the company to be a will be a key beneficiary as the Life Science Industry transitions to faster growth in 2017. Knight raised his fair value estimate on Waters shares to $200 from $185. 5. LendingClub (LC) upgraded to Positive from Neutral at Susquehanna with analyst James Friedmansaying his analysis suggests sufficient first quarter momentum to create an upward bias in 2017 and 2018 consensus forecasts. He believes the upside is not contemplated in the current valuation or the high short interest. Friedman raised his price target on LendingClub shares to $9 from $6. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/17
SUSQ
05/01/17
UPGRADE
Target $9
SUSQ
Positive
LendingClub upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst James Friedman upgraded LendingClub to Positive from Neutral as his analysis suggests sufficient Q1 momentum to create an upward bias in 2017 and 2018 consensus forecasts. He believes the upside is not contemplated in the current valuation or the high short interest. Friedman raised his price target on LendingClub shares to $9 from $6.
NCLH Norwegian Cruise Line
$56.65

-0.25 (-0.44%)

07/24/17
BOFA
07/24/17
INITIATION
Target $65
BOFA
Buy
Norwegian Cruise Line initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Andrew Didora initiated Norwegian Cruise Line with a Buy and a $65 price target saying shares trade at a discount to peers despite solid net yield trends, a newer fleet, and high margins.
05/26/17
WEDB
05/26/17
UPGRADE
WEDB
Outperform
Norwegian Cruise Line upgraded to Outperform from Neutral at Wedbush
08/02/17
GSCO
08/02/17
UPGRADE
Target $115
GSCO
Neutral
Royal Caribbean upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Stephen Grambling upgraded Royal Caribbean (RCL) to Neutral citing "strong" leisure trends following the company's better than expected Q2 results. The analyst says his sell thesis has failed to materialize. He raised his price target for the shares to $115 from $99. Grambling also raised his price target for Neutral-rated Carnival (CCL) to $68 from $60 and for Neutral-rated Norwegian Cruise Line (NCLH) to $60 from $55.
08/04/17
STFL
08/04/17
NO CHANGE
STFL
Norwegian Cruise Line should deliver beat and raise results, says Stifel
Stifel analyst Steven Wieczynski says that the results and comments of Royal Caribbean (RCL) and Carnival (CCL) indicate that Norwegian Cruise Line (NCL) will report beat and raise Q2 results. The analyst expects Norwegian, like Royal Caribbean and Carnival, to benefit from higher prices. He also expects Norwegian to be boosted by a reduction of "operational headwinds" which should enable its yield to rise more than that of its peers in 2018. The analyst keeps a $60 price target and a Buy rating on Norwegian.
BG Bunge
$77.26

0.92 (1.21%)

05/04/17
FBCO
05/04/17
NO CHANGE
Target $80
FBCO
Outperform
Bunge price target lowered to $80 from $85 at Credit Suisse
Credit Suisse analyst Robert Moskow lowered his price target for Bunge to $80 from $85 following a "highly disappointing" Q1 earnings miss and forecast reduction. While he thinks "the massive pullback" in the stock is overdone, the stock will be in the "penalty box" until the company shows some signs that it can return to more normalized margins in an oversupplied global grain market. He reiterates an Outperform rating on the shares.
05/04/17
05/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. First Solar (FSLR) upgraded to Buy from Neutral at BofA/Merrill with analyst Krish Sankar saying First Solar's execution has improved and said the low cost Series 6 product could lead to better margins starting in the second quarter of 2018. Sankar also told investors First Solar's valuation is attractive and the balance sheet has strengthened. 2. Fogo De Chao (FOGO) upgraded to Buy from Hold at Canaccord with analyst Lynne Collier saying she sees an improved outlook for the overall industry in the next 12-24 months and she has increased confidence in the company's ability to drive market share gains. Collier raised her price target to $20 from $16 on Fogo de Chao shares. 3. Carlyle Group (CG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee citing the "strong" first quarter results and accrued carry. 4. Regions Financial (RF) upgraded to Buy from Neutral at BofA/Merrill with analyst Erika Najarian saying the market is undervaluing a "significant capital return story" following the year-to-date underperformance relative to peers. The analyst sees upside to the dividend and thinks Regions can return 20% of its market capitalization over the next two years. Her price target of $17 implies 20% upside from current levels. 5. Bunge (BG) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan citing a balanced risk/reward following the 11% post-earnings selloff. The analyst keeps a $70 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/24/17
FBCO
05/24/17
NO CHANGE
FBCO
Bunge CEO, board likely to engage Glencore, says Credit Suisse
Credit Suisse analyst Robert Moskow believes Bunge (BG) CEO Soren Schroder and the company's board will engage with Glencore (GLNCY) regarding a possible tie-up. Combining with Glencore "sounds like a logical way" to address the glut of grain supplies and the persistent problem of slow farmer-selling, Moskow told investors earlier in a research note. The analyst points out that Schroder himself said in the past that the industry needs to consolidate in order to improve returns. Moskow thinks $90-$95 per share is the "right range" for a buyout of Bunge. The stock, after rallying yesterday on news of Glencore's approach, is down 33c to $81.37 in morning trading. Moskow has an Outperform rating on the shares with an $80 price target.
06/07/17
FBCO
06/07/17
NO CHANGE
Target $90
FBCO
Outperform
Bunge price target raised to $90 on increased takeover odds at Credit Suisse
Credit Suisse analyst Robert Moskow raised his price target on Bunge to $90 from $80 citing his view of a higher probability that Glencore will acquire it, as he finds it hard to believe that the company would walk away from a compelling offer. He puts a 50% probability on the stock getting to $98 per share in a Glencore takeover and a 50% chance for Bunge to rise to $82 per share if it remains independent and gets more aggressive with its strategy to create value. Moskow keeps an Outperform rating on Bunge shares, which closed yesterday at $79.29.

TODAY'S FREE FLY STORIES

AMGN

Amgen

$184.86

-1.14 (-0.61%)

12:23
06/23/18
06/23
12:23
06/23/18
12:23
Hot Stocks
Amgen's Repatha 'significantly reduced' LDL-C, non-HDL-C in Type 2 diabetes »

Amgen announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

12:18
06/23/18
06/23
12:18
06/23/18
12:18
Hot Stocks
Eli Lilly's Trulicity shows promise in delivering efficacy in type 2 diabetes »

Two investigational doses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

IRWD

Ironwood

$19.35

0.74 (3.98%)

12:14
06/23/18
06/23
12:14
06/23/18
12:14
Hot Stocks
Ironwood announced Praliciguat phase IIa study data »

Ironwood Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

12:07
06/23/18
06/23
12:07
06/23/18
12:07
Hot Stocks
Array BioPharma announces updated results from Phase 3 BEACON CRC trial »

Array BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

11:42
06/23/18
06/23
11:42
06/23/18
11:42
Periodicals
EU to respond to any U.S. auto tariffs, Reuters reports »

The EU will respond to…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

, GE

General Electric

$13.05

0.29 (2.27%)

11:27
06/23/18
06/23
11:27
06/23/18
11:27
Periodicals
Adding Walgreens to Dow may be wrong move, Barron's says »

The guardians of Dow…

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

GE

General Electric

$13.05

0.29 (2.27%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

, C

Citi

$67.20

-0.43 (-0.64%)

11:04
06/23/18
06/23
11:04
06/23/18
11:04
Periodicals
Banks to get green light to increase dividends, share repurchases, Barron's says »

Big banks are expected to…

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

C

Citi

$67.20

-0.43 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

MD

Mednax

$44.99

-0.11 (-0.24%)

10:59
06/23/18
06/23
10:59
06/23/18
10:59
Periodicals
Mednax shares may be at risk amid hospital fights, Barron's says »

After peaking in 2015,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

10:25
06/23/18
06/23
10:25
06/23/18
10:25
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

TWTR

Twitter

$45.90

0.68 (1.50%)

, FOXA

21st Century Fox

$48.59

0.25 (0.52%)

10:21
06/23/18
06/23
10:21
06/23/18
10:21
Periodicals
Biggest winner of World Cup could be Twitter, Barron's says »

Twitter's (TWTR)…

TWTR

Twitter

$45.90

0.68 (1.50%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AAPL

Apple

$184.85

-0.63 (-0.34%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:10
06/23/18
06/23
10:10
06/23/18
10:10
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$184.85

-0.63 (-0.34%)

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

STMP

Stamps.com

$252.60

0.65 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$74.81

-0.11 (-0.15%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
IntercontinentalExchange management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

AMGN

Amgen

$184.86

-1.14 (-0.61%)

, ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$184.86

-1.14 (-0.61%)

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.07

-0.52 (-2.80%)

INCY

Incyte

$74.02

1.55 (2.14%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

MRK

Merck

$61.46

0.295 (0.48%)

SHPG

Shire

$161.73

-0.7 (-0.43%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.98

0.96 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

, PCG

PG&E

$42.98

2.44 (6.02%)

18:17
06/22/18
06/22
18:17
06/22/18
18:17
Hot Stocks
Northwest Natural to sell Gill Ranch Storage to SENSA Holdings »

NW Natural (NWN)…

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

PCG

PG&E

$42.98

2.44 (6.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ORLY

O'Reilly Automotive

$285.90

-1.18 (-0.41%)

18:03
06/22/18
06/22
18:03
06/22/18
18:03
Hot Stocks
O'Reilly Automotive's O'Reilly sells 19,250 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$33.15

0.02 (0.06%)

17:46
06/22/18
06/22
17:46
06/22/18
17:46
Hot Stocks
South Jersey Industries announces approval of Elizabethtown Gas purchase »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAAS

AquaVenture

$15.36

0.12 (0.79%)

17:27
06/22/18
06/22
17:27
06/22/18
17:27
Hot Stocks
AquaVenture extends long-stop date for Ghana plant acquisition to September 30 »

AquaVenture announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Periodicals
Nissan chooses Thailand for hybrid's first export market, Nikkei reports »

Nissan has planned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Hot Stocks
Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$3.26

0.005 (0.15%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.49

-0.15 (-0.45%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Hot Stocks
Aecom to compete for $148.5M U.S. Army contract »

AECOM-Baker JV, Bryan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:17
06/22/18
06/22
17:17
06/22/18
17:17
Hot Stocks
Lockheed Martin awarded $175.3M U.S. Navy contract modification »

Lockheed Martin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:16
06/22/18
06/22
17:16
06/22/18
17:16
Hot Stocks
Lockheed Martin awarded $1.12B U.S. Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.